Why is betrixaban used?
Betrixaban is used to prevent venous thromboembolism (VTE) in hospitalized patients at risk for blood clots because of the loss or decreased ability to move around or due to other factors.
Can betrixaban cause spinal hematoma?
Spinal/Epidural Hematoma: Epidural or spinal hematomas may occur in patients treated with betrixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. The risk of these events may be increased by the use of in-dwelling epidural catheters or concomitant use of medical products affecting hemostasis. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures .
Is there a reverse agent for betrixaban?
There is NO REVERSAL AGENT OR ANTIDOTE for betrixaban. Very limited data are available to guide management of bleeding.
Does betrixaban affect coagulation?
Betrixaban is not intended to be monitored using routine coagulation testing. Its fixed dosing is not intended to be adjusted on the basis of any coagulation laboratory parameter. As a result of FXa inhibition, betrixaban prolongs clotting tests such as prothrombin time (PT)/ INR, and activated partial thromboplastin time (aPTT). Changes observed in these clotting tests at the expected therapeutic dose, however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of betrixaban
ELIGIBILITY
You may be eligible for this offer if you are insured by commercial insurance and your insurance does not cover the full cost of your prescription, or you are not insured and are responsible for the cost of your prescriptions.
TERMS OF USE
Eligible commercially insured/covered patients with no restrictions (step-edit, prior authorization, or NDC block) and with a valid prescription for BEVESPI AEROSPHERE® (glycopyrrolate 9 mcg/formoterol fumarate 4.8 mcg) who present this savings card at participating pharmacies may pay as low as $ 0, subject to a maximum savings limit of $ 100 per 30-day supply (1 inhaler); patient out-of-pocket expenses may vary.
What should I tell my doctor before taking SAVAYSA?
Before you take SAVAYSA, tell your doctor if you: have liver or kidney problems, have antiphospholipid syndrome, have ever had bleeding problems, have a mechanical heart valve, have cancer of the stomach or intestine (gastrointestinal cancer), are pregnant or plan to become pregnant, are breastfeeding or plan to breastfeed.
How should I take SAVAYSA?
Take SAVAYSA exactly as prescribed by your doctor. Your doctor will decide how long you should take SAVAYSA. Do not change your dose or stop taking SAVAYSA unless your doctor tells you to. You can take SAVAYSA with or without food. If you miss a dose of SAVAYSA, take it as soon as you remember on the same day, and do not take more than one dose at the same time. Take your next dose at your usual time the next day. Do not run out of SAVAYSA. Refill your prescription before you run out.
What is the most important information I should know about SAVAYSA?
SAVAYSA lowers your chance of having a stroke by helping to prevent clots from forming.
What are the possible side effects of SAVAYSA?
Common side effects in people who take SAVAYSA include, bleeding and low red blood cell count (anemia). Talk to your doctor if you have any side effect that bothers you or that does not go away. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the purpose of edoxaban?
Indication. SAVAYSA ® (edoxaban) is a prescription medicine used to reduce the risk of stroke and blood clots in people who have atrial fibrillation not caused by a heart valve problem. Based on how well your kidneys work, SAVAYSA may not be a treatment option for you.
